F. Pricolo

Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension

Giuseppe Derosa, Angela D’Angelo, Leonardina Ciccarelli et al. · Endothelium · 2006 · 130 citations

Medicine, Biochemistry, Cardiology +13

Metformin–pioglitazone and metformin–rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

Giuseppe Derosa, Angela D’Angelo, P. D. Ragonesi et al. · Journal of Clinical Pharmacy and Therapeutics · 2006 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +17

Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA.

Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo et al. · Hypertension Research · 2006 · 79 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Controlled Clinical Trial

Giuseppe Derosa, Arrigo F.G. Cicero, Angela D’Angelo et al. · Clinical Therapeutics · 2006 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +14

Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin

Giuseppe Derosa, Elena Fogari, Arrigo F.G. Cicero et al. · Hypertension Research · 2007 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17